2025
Scientific monographs, academic textbooks
II A. Authorship of the chapter in the monograph or academic handbook in English
Jarek A, Wójtowicz-Zawadka M, Urbaniak-Zbyszynska A, Tarka M, Chajewska K, Pasik M, Kwiatkowska D: Influence of monitoring long-term metabolites on the detection window of the selected AASs in the last decade in the Polish Anti-Doping Laboratory. Thevis M., Geyer H., Mareck U. (Eds.). Recent Advances in Doping Analysis (32). Sportverlag Strauss, Köln 2024, pp. 77-79 (opublikowane w 2025)
Kaliszewski P, Zamlynski M, Zalewska Z, Grucza K, Woznica M, Zamlynski J, Olejek A, Kwiatkowska D: Is pregnancy a confounding factor for hGH detection by using the biomarkers method? Thevis M., Geyer H., Mareck U. (Eds.). Recent Advances in Doping Analysis (32). Sportverlag Strauss, Köln 2024, pp. 80-82 (opublikowane w 2025)
Grucza K, Wicka M, Drapala A, Konarski P, Bedecka M, Kaliszewski P, Stanczyk D, Kwiatkowska D: Monitoring of a potentially valuable metabolite of indapamide in routine doping control. Thevis M., Geyer H., Mareck U. (Eds.). Recent Advances in Doping Analysis (32). Sportverlag Strauss, Köln 2024, pp. 83-88 (opublikowane w 2025)
VI C. Summaries and congressional announcements
Wicka M, Drapala A, Wojtkowiak K, Grucza K, Konarski P, Bedecka M, Kwiatkowska D: Elimination profile of semaglutide and its metabolite in human urine. Thevis M., Geyer H., Mareck U. (Eds.). Recent Advances in Doping Analysis (32). Sportverlag Strauss, Köln 2024, pp. 294-295 (opublikowane w 2025)
Wicka M, Drapala A, Wojtkowiak K, Grucza K, Konarski P, Bedecka M, Kwiatkowska D: Identification of compounds used in therapy for type 2 diabetes as potential doping substances with particular emphasis on glucagonlike peptide-1 (GLP-1) analogues. Thevis M., Geyer H., Mareck U. (Eds.). Recent Advances in Doping Analysis (32). Sportverlag Strauss, Köln 2024, pp. 296-297 (opublikowane w 2025)